{"id":19299,"date":"2022-03-07T16:55:40","date_gmt":"2022-03-07T16:55:40","guid":{"rendered":"https:\/\/zeepedia.com\/?p=19299"},"modified":"2022-03-08T11:46:24","modified_gmt":"2022-03-08T11:46:24","slug":"numeta-g13e","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/numeta-g13e\/","title":{"rendered":"Numeta G13E uses, dose and side effects"},"content":{"rendered":"\n<p>infusion solution, emulsion<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Numeta G13E is and what it is used for<\/h2>\n\n\n\n<p>Numeta G13E is an&nbsp;emulsion&nbsp;that contains nutrients specially designed for premature babies.&nbsp;It is given through a tube that is placed in your child&#8217;s vein when your child can not get all the nutrition he or she needs by eating.<\/p>\n\n\n\n<p>Numeta G13E is supplied as a three-chamber bag\u00a0where the separate chambers contain:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>50 mg \/ ml glucose solution (sugar)<\/li><li>5.9 mg \/ ml amino acid solution and&nbsp;electrolytes&nbsp;(&nbsp;protein&nbsp;building blocks and salts)<\/li><li>12.5 mg \/ ml lipid emulsion (fat).<\/li><\/ul>\n\n\n\n<p>Depending on your child&#8217;s needs, two or three of these solutions are mixed inside the infusion bag, before the medicine is given to your child.<\/p>\n\n\n\n<p>The use of Numeta G13E must be done under medical supervision.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before your child receives Numeta G13E<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Your child should not receive Numeta G13E in the following cases:<\/h2>\n\n\n\n<p><strong>When the solutions\u00a0glucose\u00a0and amino acid\/electrolyte are mixed in the bag (&#8220;2 in 1&#8221;):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if your child is allergic to eggs, soy, peanuts or any of the other ingredients of this medicine or any of the ingredients in the bag (listed in section 6).<\/li><li>if your child&#8217;s body can not utilize the building blocks of&nbsp;protein&nbsp;.<\/li><li>if your child has high blood levels of any of the&nbsp;electrolytes&nbsp;contained in Numeta G13E.<\/li><li>Numeta G13E (or other&nbsp;calcium&nbsp;-containing solutions ) must not be given concomitantly with ceftriaxone (an&nbsp;antibiotic&nbsp;), even if separate infusion lines are used.&nbsp;There is a risk of particles forming in the newborn&#8217;s bloodstream, which can be fatal.<\/li><li>if your child has&nbsp;hyperglycaemia&nbsp;(too high blood sugar).<\/li><\/ul>\n\n\n\n<p><strong>When the solutions with\u00a0glucose<\/strong>, amino acid\/electrolyte,<strong> and lipid emulsion are mixed in the bag (&#8220;3 in 1&#8221;).<\/strong><\/p>\n\n\n\n<p>In all the above situations mentioned for &#8220;2 in 1&#8221; and the following:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if your child has high blood fat levels.<\/li><\/ul>\n\n\n\n<p>In all cases, the doctor should base his decision on possible treatment with Numeta G13E on factors such as age, weight, and clinical condition.\u00a0The doctor will also take into account the results of any tests performed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and cautions<\/h2>\n\n\n\n<p>Talk to your child&#8217;s doctor or nurse before giving your child Numeta G13E.<\/p>\n\n\n\n<p>When used to treat newborns and children under 2 years of age, the solution (in sachets and administration sets) should be protected from light exposure until\u00a0the administration\u00a0is complete.\u00a0If Numeta G13E is exposed to ambient light, especially after the addition of trace elements and\/or\u00a0vitamins, peroxides and other degradation products are formed, which can be reduced if the product is protected from light exposure.<\/p>\n\n\n\n<p><strong>Allergic reactions:<\/strong><\/p>\n\n\n\n<p>The infusion\u00a0must be stopped immediately if any signs or symptoms of\u00a0an allergic reaction\u00a0(such as fever, sweating, chills, headache, rash, or difficulty breathing) develop.\u00a0This medicine contains soybean oil, which in rare cases may cause\u00a0hypersensitivity reactions.\u00a0In less common cases, it has been seen that some people who are allergic to peanut protein are also allergic to soy protein.<\/p>\n\n\n\n<p>Numeta G13E contains&nbsp;glucose&nbsp;made from corn starch.&nbsp;Numeta G13E should be used with caution in patients with known&nbsp;allergies&nbsp;to maize or maize products.<\/p>\n\n\n\n<p><strong><em>Risk of particulate matter with ceftriaxone (an antibiotic):<\/em><\/strong><\/p>\n\n\n\n<p>A certain\u00a0antibiotic, called ceftriaxone, must not be mixed or given at the same time as calcium-containing solutions (including Numeta G13E) as it is given to you as a drip into a vein.<br>Your doctor will know about this and will not give them to you together, not even through different infusion tubes or at different infusion sites.<\/p>\n\n\n\n<p><strong>Formation of small particles in the blood vessels of the lungs:<\/strong><\/p>\n\n\n\n<p>Breathing difficulties may be a sign that small particles have formed that block the blood vessels in the lungs (&nbsp;pulmonary&nbsp;vascular&nbsp;deposits).&nbsp;Talk to your doctor or nurse if your child has difficulty breathing.&nbsp;They will decide on appropriate measures.<\/p>\n\n\n\n<p><strong>Infection&nbsp;and blood poisoning:<\/strong><\/p>\n\n\n\n<p>Your doctor will closely monitor your child for any signs of\u00a0infection.\u00a0The use of aseptic technology (a technology free of bacteria) when placing and maintaining the catheter, as well as when preparing the nutrient solution, can reduce the risk of\u00a0infection.<\/p>\n\n\n\n<p>Sometimes children can develop\u00a0infection\u00a0and\u00a0sepsis\u00a0(bacteria in the blood) when they have a tube in a vein (\u00a0intravenous\u00a0catheter\u00a0).\u00a0Some medicines and diseases may increase the risk of\u00a0developing\u00a0infection\u00a0or\u00a0sepsis.\u00a0Patients who need\u00a0parenteral\u00a0nutrition (feeding via a tube into your baby&#8217;s blood vessels) may find it easier to develop an\u00a0infection\u00a0due to their medical condition.<\/p>\n\n\n\n<p><strong>Fat overload syndrome:<\/strong><\/p>\n\n\n\n<p>Fat overload syndrome has been reported for similar drugs.&nbsp;If your body has reduced or decreased ability to get rid of the fats in Numeta G13E, \u201cfat overload syndrome\u201d may occur (see section 4 &#8211; Possible&nbsp;side effects&nbsp;).<\/p>\n\n\n\n<p><strong>Changes in blood chemical levels:<\/strong><\/p>\n\n\n\n<p>Your doctor will check and monitor your baby&#8217;s fluid levels, blood chemical balance, and other blood levels during treatment with Numeta G13E.\u00a0Nutritional supply to someone who is severely malnourished can sometimes lead to changes in the blood&#8217;s chemical levels that may need to be corrected.\u00a0Extra fluid in the\u00a0tissues\u00a0and swelling may also develop.\u00a0It is recommended that\u00a0parenteral\u00a0nutrition be started slowly and carefully.<\/p>\n\n\n\n<p><strong>Monitoring and adjustment:<\/strong><\/p>\n\n\n\n<p>Your doctor will closely monitor and adjust the\u00a0dose\u00a0of Numeta G13E to suit your child&#8217;s special needs if the child has the following conditions:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>severe post-traumatic stress disorder<\/li><li>severe&nbsp;diabetes mellitus&nbsp;(diabetes)<\/li><li>shock<\/li><li>heart attack<\/li><li>severe&nbsp;infection<\/li><li>certain types of&nbsp;coma<\/li><\/ul>\n\n\n\n<p><strong>Use with caution in:<\/strong><\/p>\n\n\n\n<p>Numeta G13E should be used with caution if the child has:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>pulmonary edema&nbsp;(fluid in the lungs) or&nbsp;heart failure<\/li><li>severe liver problems<\/li><li>difficulty in absorbing nutrients<\/li><li>high blood sugar<\/li><li>kidney problems<\/li><li>severe metabolic disorders (when various substances are not normally broken down in the body)<\/li><li>coagulation disease (disorders of the blood&#8217;s ability to clot).<\/li><\/ul>\n\n\n\n<p>The baby&#8217;s fluid status, liver values \u200b\u200b, and\/or blood values \u200b\u200bwill be closely monitored.<\/p>\n\n\n\n<p>There is only limited information on the administration of the medicine to premature infants born before week 28.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Other medicines and Numeta G13E<\/h2>\n\n\n\n<p>Tell your doctor if your child is taking, has recently taken, or might take any other medicines.<\/p>\n\n\n\n<p><strong>Numeta G13E must not be given at the same time as:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>ceftriaxone<\/strong>&nbsp;(an&nbsp;antibiotic&nbsp;), also via different infusion lines due to the risk of particle formation.<\/li><li><strong>blood<\/strong>&nbsp;through the same infusion set due to the risk of<\/li><li>pseudoagglutination (that the red&nbsp;blood cells&nbsp;clump together).<\/li><li><strong>ampicillin, phosphenytoin or&nbsp;furosemide<\/strong>&nbsp;via the same infusion lines due to the risk of particle formation.<\/li><\/ul>\n\n\n\n<p><strong>Coumarin and&nbsp;warfarin&nbsp;(blood thinners):<\/strong><\/p>\n\n\n\n<p>Your doctor will closely monitor your child if the child is being treated with coumarin and\u00a0warfarin.\u00a0It is a blood-thinning drug that is used to prevent blood from clotting and preventing blood clots.\u00a0Olive and soybean oil naturally contain\u00a0vitamin\u00a0K1.\u00a0Vitamin\u00a0K1 can affect the effects of drugs such as coumarin and\u00a0warfarin.<\/p>\n\n\n\n<p><strong>Laboratory tests:<\/strong><\/p>\n\n\n\n<p>The lipids&nbsp;in this&nbsp;emulsion&nbsp;may affect the results of certain laboratory tests.&nbsp;Laboratory samples can be taken after 5 to 6 hours if no additional&nbsp;lipids&nbsp;are given.<\/p>\n\n\n\n<p><strong>Effect of Numeta G13E with medicines that may affect potassium levels\/degradation:<\/strong><\/p>\n\n\n\n<p>Numeta G13E contains\u00a0potassium.\u00a0High levels of\u00a0potassium\u00a0in the blood can cause abnormal heart rhythms.\u00a0Particular caution should be exercised in patients taking\u00a0diuretics\u00a0(\u00a0diuretics\u00a0) or\u00a0ACE inhibitors\u00a0(\u00a0antihypertensive\u00a0drugs ), angiotensin\u00a0II receptor antagonists (\u00a0antihypertensive\u00a0drugs ), or immunosuppressive drugs (drugs that may\u00a0inhibit\u00a0the body&#8217;s normal immune system).\u00a0These types of drugs can raise potassium levels.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to get Numeta G13E<\/h2>\n\n\n\n<p>Your child should always receive Numeta G13E according to their doctor&#8217;s instructions.&nbsp;Consult a doctor if you are unsure.<\/p>\n\n\n\n<p><strong>Age groups<\/strong><\/p>\n\n\n\n<p>Numeta G13E has been developed to meet the nutritional needs of premature babies.<\/p>\n\n\n\n<p>Numeta G13E may be unsuitable for some premature babies, as their condition may require individualized formulations to meet their specific nutritional needs.&nbsp;Your doctor will decide if this medicine is suitable for your child.<\/p>\n\n\n\n<p><strong>Administration<\/strong>&nbsp;<\/p>\n\n\n\n<p>This medicine is an\u00a0emulsion\u00a0for\u00a0infusion.\u00a0It is given through a plastic tube into a vein in your baby&#8217;s armor into a large vein in your baby&#8217;s breast.<\/p>\n\n\n\n<p>Your doctor may choose not to give\u00a0your baby\u00a0lipids (fats).\u00a0The bag with Numeta G13E is designed so that only the seal between the chambers with amino acids\/electrolytes and\u00a0glucose\u00a0can be broken if necessary.\u00a0The closure between the chambers of\u00a0amino acids\u00a0and\u00a0lipids\u00a0then remains intact.\u00a0The contents of the bag can then be infused without\u00a0lipids.<\/p>\n\n\n\n<p>When used to treat newborns and children under 2 years of age, the solution (in sachets and administration sets) should be protected from exposure to light until\u00a0the administration\u00a0is complete (see section 2).<\/p>\n\n\n\n<p><strong>Dosage&nbsp;and duration of treatment<\/strong><\/p>\n\n\n\n<p>The doctor decides what\u00a0dose\u00a0the child should receive and for how long the medicine should be given.\u00a0Dose\u00a0one depends on the child&#8217;s nutritional needs.\u00a0Dosage\u00a0one is determined based on the child&#8217;s weight, medical condition, and the body&#8217;s ability to break down and assimilate the ingredients in Numeta G13E.\u00a0Extra nutrients or\u00a0protein\u00a0can also be given, either by mouth or as\u00a0an infusion\u00a0into the bloodstream.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">If your child has been given too much Numeta G13E<\/h2>\n\n\n\n<p>If you have ingested too much medicine or if e.g.\u00a0If a child has ingested the medicine by mistake, contact a doctor, hospital for risk assessment and advice.<\/p>\n\n\n\n<p><strong>Symptoms<\/strong><\/p>\n\n\n\n<p>Too much of this medicine or giving it too fast can lead to the following:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>nausea<\/li><li>vomiting<\/li><li>overindulge<\/li><li>electrolyte disturbances (inappropriate amounts of&nbsp;electrolyte&nbsp;in your blood)<\/li><li>signs of&nbsp;hypervolemia&nbsp;(increased circulating blood volume)<\/li><li>acidosis&nbsp;(increased acidity of the blood).<\/li><\/ul>\n\n\n\n<p>In such situations, the&nbsp;infusion&nbsp;must be stopped immediately.&nbsp;Your doctor will decide if further action is required.<\/p>\n\n\n\n<p>To prevent this, your doctor should regularly monitor your child&#8217;s condition and test your child&#8217;s blood counts during treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p>If you notice any change in how your child feels during or after treatment, contact a doctor or nurse immediately.<\/p>\n\n\n\n<p>The tests that your doctor performs while your child is taking this medicine should minimize the risk of\u00a0side effects.<\/p>\n\n\n\n<p>If signs of an&nbsp;allergic reaction&nbsp;occur, the&nbsp;infusion&nbsp;should be stopped immediately and a doctor consulted.&nbsp;This can be serious and the symptoms can be:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>sweating<\/li><li>overindulge<\/li><li>headache<\/li><li>rash<\/li><li>breathing difficulties<\/li><\/ul>\n\n\n\n<p>Other&nbsp;side effects&nbsp;that have been observed are:<\/p>\n\n\n\n<p><em>Common: may affect up to 1 in 10 users<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Low level of phosphate in the blood (&nbsp;hypophosphatemia&nbsp;)<\/li><li>High blood sugar (&nbsp;hyperglycaemia&nbsp;)<\/li><li>High calcium levels in the blood (&nbsp;hypercalcaemia&nbsp;)<\/li><li>High blood triglyceride levels (&nbsp;hypertriglyceridemia&nbsp;)<\/li><li>Electrolyte disturbances (&nbsp;hyponatremia&nbsp;).<\/li><\/ul>\n\n\n\n<p><em>Uncommon: may affect up to 1 in 100&nbsp;<\/em><em>people<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>High levels of fats in the blood (&nbsp;hyperlipidemia&nbsp;)<\/li><li>Conditions where bile can not flow from the liver to the&nbsp;duodenum&nbsp;(bile stasis).&nbsp;The duodenum&nbsp;is one of the intestines<\/li><\/ul>\n\n\n\n<p><em>Has been reported: occurs in an unknown number of users<\/em>&nbsp;(These&nbsp;side effects&nbsp;have only been reported for Numeta G13E and G16E administered peripherally and in insufficient dilution).<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Skin necrosis<\/li><li>Soft tissue injury<\/li><li>Leakage of the drug outside the blood vessel (extravasation).<\/li><\/ul>\n\n\n\n<p>The following&nbsp;side effects&nbsp;have been reported with other&nbsp;parenteral&nbsp;nutrition drugs:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Decreased or limited ability to get rid of the fats in Numeta G13E can lead to &#8220;fat overload syndrome&#8221;.&nbsp;The following signs and symptoms of this syndrome are usually&nbsp;reversible&nbsp;when&nbsp;infusion&nbsp;one of the lipid emulsions is stopped:<ul><li>Sudden and abrupt deterioration of the patient&#8217;s medical condition.<\/li><li>High levels of fat in the blood (&nbsp;hyperlipidemia&nbsp;).<\/li><li>Fever.<\/li><li>Fatty infiltration of the liver (&nbsp;hepatomegaly&nbsp;).<\/li><li>Impaired liver function.<\/li><li>Decreased number of&nbsp;red blood cells&nbsp;(&nbsp;anemia&nbsp;), which can lead to pale skin and cause weakness or shortness of breath.<\/li><li>Low&nbsp;white blood cell count&nbsp;(&nbsp;leukopenia&nbsp;), which may increase the risk of infection.<\/li><li>Low&nbsp;platelet count&nbsp;(&nbsp;thrombocytopenia&nbsp;), which may increase the risk of bruising and \/ or bleeding.<\/li><li>Coagulation disorders that affect the blood&#8217;s ability to coagulate.<\/li><li>Coma&nbsp;, which requires hospitalization.<\/li><\/ul><\/li><li>Formation of small particles that can block the blood vessels in the lungs (&nbsp;pulmonary&nbsp;vascular deposits) or difficulty breathing.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">How to store Numeta G13E<\/h2>\n\n\n\n<p>Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n<p>When used to treat newborns and children under 2 years of age, the solution (in sachets and administration sets) should be protected from exposure to light until\u00a0the administration\u00a0is complete (see section 2).<\/p>\n\n\n\n<p>Do not use this medicine after the expiry date which is stated on the bag and the outer carton after EXP.&nbsp;The expiration date is the last day of the specified month.<\/p>\n\n\n\n<p>Do not freeze.<\/p>\n\n\n\n<p>Store in the outer bag.<\/p>\n\n\n\n<p>Medicines should not be disposed of via wastewater or household waste.&nbsp;Ask your pharmacist how to dispose of medicines no longer required.&nbsp;These measures will help to protect the environment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the package and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">What the medicine looks like and contents of the pack<\/h2>\n\n\n\n<p>Numeta G13E is supplied in a bag with three chambers.\u00a0Each bag contains a\u00a0sterile\u00a0combination of a glucose solution, an amino acid solution for children with\u00a0electrolytes,\u00a0and a lipid emulsion as described below.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Package size<\/strong><\/td><td><strong>50 g \/ 100 ml glucose solution<\/strong><\/td><td><strong>5.9 g \/ 100 ml amino acid&nbsp;solution with&nbsp;electrolytes<\/strong><\/td><td><strong>12.5 g \/ 100 ml lipid emulsion<\/strong><\/td><\/tr><tr><td>300 ml<\/td><td>80 ml<\/td><td>160 ml<\/td><td>60 ml<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Appearance before preparation:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The solutions in the&nbsp;amino acid&nbsp;and glucose chambers are clear, colorless or slightly yellow.<\/li><li>The chamber with the lipid emulsion contains a&nbsp;homogeneous&nbsp;liquid with a milk-like appearance.<\/li><\/ul>\n\n\n\n<p>Appearance after preparation:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The 2-in-1 solution (amino acid \/ electrolyte and&nbsp;glucose&nbsp;) for&nbsp;infusion&nbsp;is clear, colorless or pale yellow<\/li><li>&#8220;3 in 1&#8221;&nbsp;emulsion&nbsp;for&nbsp;infusion&nbsp;is&nbsp;homogeneous&nbsp;and milky.<\/li><\/ul>\n\n\n\n<p>The bag with three chambers is made of multilayer plastic.<\/p>\n\n\n\n<p>To avoid contact with the air, the Numeta G13E is packaged in an outer bag with an oxygen barrier that also contains an oxygen-absorbing bag and an oxygen indicator.<\/p>\n\n\n\n<p><strong>Pack sizes<\/strong><\/p>\n\n\n\n<p>300 ml bag: 10 pcs in each carton<\/p>\n\n\n\n<p>1 bag with 300 ml<\/p>\n\n\n\n<p>Not all pack sizes may be marketed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n<p><em>Marketing Authorisation Holder<\/em><\/p>\n\n\n\n<p>Baxter Medical AB<\/p>\n\n\n\n<p>Box 63<\/p>\n\n\n\n<p>164 94 Kista<\/p>\n\n\n\n<p><em>Manufacturer<\/em><\/p>\n\n\n\n<p>Baxter SA<\/p>\n\n\n\n<p>Boulevard Rene Branquart, 80<\/p>\n\n\n\n<p>7860 Lessines<\/p>\n\n\n\n<p>Belgium<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Numeta G13E is an emulsion that contains nutrients specially designed for premature babies. It is given through a tube that is placed in your child&#8217;s vein when your child can not get all the nutrition he or she needs by eating.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,15581],"tags":[19320,19316,19323,19321,19319,19322,19317,19318],"class_list":["post-19299","post","type-post","status-publish","format-standard","hentry","category-medicines","category-n","tag-benefits-of-numeta-g13e","tag-numeta-g13e","tag-numeta-g13e-dosage","tag-numeta-g13e-nutrition","tag-numeta-g13e-side-effects","tag-numeta-g13e-usage","tag-what-is-numeta-g13e","tag-what-numeta-g13e-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=19299"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19299\/revisions"}],"predecessor-version":[{"id":19337,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19299\/revisions\/19337"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=19299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=19299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=19299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}